National Heart, Lung, and Blood Institute; Amended Notice of Meeting, 24601 [E8-9759]

Download as PDF Federal Register / Vol. 73, No. 87 / Monday, May 5, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings rfrederick on PROD1PC67 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group, Diabetes, Endocrinology and Metabolic Diseases B Subcommittee. Date: June 12–13, 2008. Open: June 12, 2008, 5 p.m. to 5:30 p.m. Agenda: To review procedures and discuss policy Place: San Francisco Marriott, 55 Fourth Street, San Francisco, CA 94103. Closed: June 12, 2008, 5:30 p.m. to 9 p.m. Agenda: To review and evaluate grant applications. Place: San Francisco Marriott, 55 Fourth Street, San Francisco, CA 94103. Closed: June 13, 2008, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: San Francisco Marriott, 55 Fourth Street, San Francisco, CA 94103. Contact Person: John F. Connaughton, PhD, Chief, Chartered Committees Section, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7797, connaughtonj@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group, Kidney, Urologic and Hematologic Diseases D Subcommittee. Date: June 25–26, 2008. Open: June 25, 2008, 8 a.m. to 8:30 a.m. Agenda: To review procedures and discuss policy. VerDate Aug<31>2005 15:16 May 02, 2008 Jkt 214001 Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Closed: June 25, 2008, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Closed: June 26, 2008, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Barbara A. Woynarowska, PhD, Scientific Review Administrator, Review Branch, Dea, NIDDK, National Institutes of Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 402–7172, woynarowskab@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: April 28, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9758 Filed 5–2–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Clinical Trials Review Committee, June 30, 2008, 8:30 a.m. to July 1, 2008, 5 p.m., Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202 which was published in the Federal Register on April 22, 2008, FRE8–8513. The meeting dates were changed from June 30–July 1, 2008 to June 23–24, 2008. Also, meeting location was changed from Pier 5 Hotel to Sheraton Columbia Hotel. The rest of the information remains the same. The meeting is closed to the public. Dated: April 28, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9759 Filed 5–2–08; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 24601 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review of RFA DE–08–006 and RFA DE–08–007 Osteoimmunology— Crosstalk between Immune System and Bone. Date: June 3, 2008. Time: 8 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza—Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Rebecca Wagenaar Miller, PhD, Scientific Review Officer, Scientific Review Branch, National Inst of Dental & Craniofacial Research, National Institutes of Health, 6701 Democracy, Rm 666, Bethesda, MD 20892, 301–594–0652, rwagenaa@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: April 28, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9755 Filed 5–2–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. E:\FR\FM\05MYN1.SGM 05MYN1

Agencies

[Federal Register Volume 73, Number 87 (Monday, May 5, 2008)]
[Notices]
[Page 24601]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-9759]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Amended Notice of 
Meeting

    Notice is hereby given of a change in the meeting of the Clinical 
Trials Review Committee, June 30, 2008, 8:30 a.m. to July 1, 2008, 5 
p.m., Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202 which was 
published in the Federal Register on April 22, 2008, FRE8-8513.
    The meeting dates were changed from June 30-July 1, 2008 to June 
23-24, 2008. Also, meeting location was changed from Pier 5 Hotel to 
Sheraton Columbia Hotel. The rest of the information remains the same. 
The meeting is closed to the public.

    Dated: April 28, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-9759 Filed 5-2-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.